Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
“Regenerative pathway activation” refers to the upregulation or initiation of endogenous cellular signaling networks that control tissue repair and the regrowth of organs or body parts after damage. This concept covers numerous molecular pathways—such as Notch, Wnt/β-catenin, Hippo-YAP, and BMP/Runx2 signaling—that modulate cell cycle entry, proliferation, differentiation, and stem/progenitor cell function in various contexts. While these pathways are fundamental to regenerative medicine, 'regenerative pathway activation' itself is not a single, discrete target, but a multi-factorial process involving many molecules. Therapeutic interventions may aim to modulate these pathways to enhance tissue repair after injury, but specific druggable targets must be defined on a pathway- or molecule-specific basis.
Activation of developmental signaling pathways (e.g., Notch, Wnt/β-catenin, Hippo-Yap, PI3K/Akt, BMP/Runx2) Promotion of cell cycle re-entry in differentiated cells Modulation of stem and progenitor cell activity
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Regenerative pathway activation.